Brain graphic About Neurology ReviewsFeatured IssuesEditorial BoardPublishing StaffAdvertising InformationSubscription InformationOnline CME from Clinicians GroupCareer Center

Search:
Sort by:


Neurology Reviews.Com

Vol. 11, No. 5
May 2003


DIAPHRAGM NERVE PACING MAY HELP CHRISTOPHER REEVE BREATHE

Christopher Reeve, whose recovery from severe upper spinal cord injury continues to fascinate researchers, became the third patient to try an experimental device that stimulates the diaphragm and permits ventilator-independent breathing. Researchers Anthony F. DiMarco, MD, Raymond Onders, MD, and colleagues at Case Western Reserve University in Cleveland developed the device, which requires only laparoscopic surgery and does not carry the risks associated with traditional phrenic nerve pacing.

Dr. DiMarco told Neurology Reviews, “Our goal is to provide something safer and less expensive than conventional phrenic nerve pacing. Our experience so far suggests that diaphragm pacing provides an overall improved sense of well-being and enables the patient not only to breathe but also to speak more normally. There are also social benefits, since in a casual setting you really can’t tell that a patient is being paced by this device.”

SETTING THE PACE

The procedure for Mr. Reeve was substantially the same as that used in the initial case the investigators reported last year except that they are now using only suction electrodes to identify target areas in the diaphragm rather than the elaborate fine mapping technique described in that report.

Briefly, four trocars are placed into the abdominal wall and a pneumoperitoneum is created. Suction electrodes are used to identify the phrenic nerve motor points, where the phrenic nerves enter the diaphragm. Two stainless steel intramuscular diaphragm electrodes are inserted into the motor points of each hemidiaphragm in the same plane as the diaphragm. Wires from the four electrodes are brought out through the epigastric port, leaving some slack to allow movement, tunneled subcutaneously to the chest, and attached to a connecting circuit. Each wire is then tunneled subcutaneously to the right or left subclavicular region, where the wires exit the chest wall.

Following a 10- to 14-day recovery period, the researchers attach a four-channel electrical stimulator about the size of two decks of playing cards to the four electrodes. This is programmed to produce regular contractions (“pacing”) of the diaphragm. During a period of 14 to 20 weeks, the patient switches from the ventilator to progressively longer periods of pacing.

The first patient to use Dr. DiMarco’s device has been free of mechanical ventilation for two years, continues to do well, and has a maximum inspired volume of more than 1,200 mL. In the second patient, however, the device was not successful. “There was no inspiratory action at all, and we are still trying to figure out why,” Dr. DiMarco said. “We suspect that there were unrecognized problems in phrenic nerve function in this patient.”

BREATHING EASIER?

Traditional phrenic nerve pacing requires thoracotomy and direct insertion of electrodes into the nerve. Dr. DiMarco estimated the cost at about $60,000 for the equipment plus $10,000 to $15,000 for hospitalization. The diaphragm pacing equipment is expected to cost less than $30,000 and is implanted in a laparoscopic procedure, so patients go home the same day and do not require expensive hospitalization.

The method for implanting the device is fairly easy to learn, said Dr. DiMarco, and it should eventually be available in most major referral hospitals. Widespread commercial availability of the device is about two years away, but Dr. DiMarco remarked that if all goes well with the next 10 patients, his group will consider marketing it, as they are legally entitled to do under their investigational device exemption. Meanwhile they are also trying to raise funds for testing it in the 25 to 35 patients needed to obtain full approval from the FDA.

The investigators are now working on a radio-controlled version of the device, which would eliminate the need for wires exiting the chest. “We expect that within about two years we will have a smaller, radio-controlled, completely implantable unit,” Dr. DiMarco said.

NR

—Janis Kelly

Suggested Reading
DiMarco AF, Onders RP, Kowalski KE, et al. Phrenic nerve pacing in a tetraplegic patient via intramuscular diaphragm electrodes. Am J Respir Crit Care Med. 2002; 166:1604-1606.

Return to table of contents